Buschke-Löwenstein Tumor: Report of a New Case
Journal Title: Scholars Journal of Medical Case Reports - Year 2018, Vol 6, Issue 4
Abstract
Giant condyloma acuminatum also known as Buschke–Lowenstein tumour (BLT) is regarded as an entity intermediate between an ordinary condyloma acuminatum and squamous cell carcinoma. We report the case of a 65-year-old male patient with a 22 years history of a penoscrotal BLT managed by surgical excision alone.
Authors and Affiliations
Kamal Moufid, Abderrezak Benazzouz, Omar Ghoundale, Driss Touiti
Keywords
Related Articles
- EP ID EP484274
- DOI -
- Views 64
- Downloads 0
Cytodiagnosis of Metastatic Renal Cell Carcinoma Presenting As a Solitary Nodule on Arm: A Case Report and Review of Literature
Renal cell carcinoma (RCC) contributes in being only 3% of all the solid organ tumors. Skin metastasis occurs in only 3-5% of the RCCs. Cytodiagnosis of the cutaneous metastasis of RCC may be difficult owing to its pres...
Hemiparesis Due to Subarachnoid Hemorrhage
An 85-year-old female was found in coma state in a toilet at a public spa area. Her Glasgow Coma Scale in total was 6 and she had isocoric reactive pupil. She had right hemiparesis. The CT examination demonstrated a sub...
Juxta Axillary Granular Cell Tumor
Granular cell tumors or Abrikossoff tumors are very rare, benign and unique tumors in the vast majority of cases, described for the first time in 1926, and can mimicking carcinoma clinically and radiologically. The commo...
Sub acute Sclerosing Pan encephalitis in a child with early onset Huntington’s Disease
Onset of Huntington’s disease (HD) before 10 years constitutes less than 1% of all patients with HD. We report 5 year old boy with complex presentation having features of both Sub acute Sclerosing Pan encephalitis (SSPE)...
Challenges in Managing Locally Aggressive Pelvic Chondrosarcoma: A Case Report
Chondrosarcoma (CS) is a primary bone malignancy which differentiated from the cartilage tissue. It accounts for approximately 20% of malignant bone tumours. It ranks the third most common primary bone malignancy after o...